Dr. Deborah “Debs” Payne is the Vice President of Clinical Trials and Development, Senior Scientific Officer and Clinical Consultant for American Pathology Partners. Prior to joining in 2009, she served as Director of the Molecular Diagnostic Laboratory of the University of Texas Southwestern Medical Center in Dallas, TX where she was also Associate Professor of Pathology. She was also Director and founded the Division of Molecular Diagnostics in the Department of Pathology at the University of Texas Medical Branch in Galveston, TX. Dr. Payne received her PhD in Microbiology and Immunology from the University of Texas Medical Branch; and performed part of her post-doctoral training within the National Aeronautics and Space Administration (NASA) located at the Johnson Space Center in Houston, TX.
In 2009, she joined American Pathology Partners and developed their molecular diagnostic offering that performs more than 43,000 molecular tests per month. Dr. Payne is nationally recognized in molecular diagnostics, is an active speaker, well published and active member of numerous committees and industry organizations. She has held offices as the Chair of the Training and Education Committee for the Association of Molecular Pathology, as Chair of the Molecular Pathology division for the American Association for Clinical Chemistry (AACC), as the Co-Chair for the NACB Laboratory Practice Guidelines Committee on Pharmacogenetics, voting member for the Molecular and Clinical Genetics Devices Panel of the Medical Devices Advisory Committee of the Food and Drug Administration (i.e., CDRH-FDA), editorial board for LabMedicine, Board of Directors for the American Board of Clinical Chemistry (ABCC), President of the ABCC, member of the Center for Disease Control committee on reference materials (GetRM), and as an advisor to the Clinical Laboratory Standards Institute (CLSI). She is the Chair of the Molecular Diagnostics Committee for the International Federation of Clinical Chemists (IFCC), executive board member for the AACC Molecular Pathology division and is an Associate Editor of the journal Clinical Chemistry and Laboratory Medicine (CCLM).
Dr. Payne has authored/coauthored more than 6 book chapters, 60 manuscripts and has been the Principle Investigator for numerous clinical trials and grants. She is licensed by the New York Department of Health in the following areas: Bacteriology, Mycology, Parasitology, Virology, Oncology and Molecular/Cellular Tumor Markers. She is certified as a clinical laboratory scientist-specialist in Molecular Biology [MB(ASCP)], Diplomate in Laboratory Management [DLM(ASCP)], is a Fellow of the National Academy of Clinical Biochemistry (FACB) and is board certified by the American Board of Clinical Chemistry in Molecular Diagnostics (DABCC) and by the American Board of Medical Microbiology (DABMM).